Listed

Monopar Therapeutics

MNPRNasdaqCIK 1645469HealthcareFiscal year ends Dec 31

Reports and events: 180 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Monopar Therapeutics, Reports and events
FiledFormWhat it isAccession number
2024-08-1408:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-24-026563
2024-08-0908:02 ET10-QQuarterly reportPeriod 2024-06-300001437749-24-025651
2024-08-0908:01 ET8-K2.02 Results of operations; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001437749-24-025650
2024-07-2207:00 ETDEF 14AProxy statementPeriod 2024-08-050001437749-24-023123
2024-07-0916:01 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-24-022403
2024-06-1107:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-24-019881
2024-06-1008:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-24-019747
2024-05-2408:00 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-24-018249
2024-05-0907:00 ET10-QQuarterly reportPeriod 2024-03-310001437749-24-015454
2024-05-0907:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001437749-24-015453
2024-04-1608:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-24-012131
2024-04-1008:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-24-011573
2024-03-2807:01 ET10-KAnnual reportPeriod 2023-12-310001437749-24-009687
2024-03-2807:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001437749-24-009686
2024-03-0708:30 ET8-K7.01 Regulation FD disclosure0001437749-24-006900
2024-03-0507:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-24-006538
2024-02-2813:45 ET8-K3.01 Delisting notice0001437749-24-005871
2024-02-2706:59 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-24-005624
2024-02-2207:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-24-005127
2024-02-2008:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-24-004724
2023-11-0907:01 ET10-QQuarterly reportPeriod 2023-09-300001437749-23-031066
2023-11-0907:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001437749-23-031065
2023-11-0107:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-23-029657
2023-08-3017:16 ET8-K3.01 Delisting notice0001437749-23-024891
2023-08-1007:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001437749-23-022875
2023-08-1007:00 ET10-QQuarterly reportPeriod 2023-06-300001437749-23-022874
2023-08-0807:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-23-022388
2023-07-1107:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-23-019665
2023-06-2816:13 ET8-K5.07 Shareholder vote results0001437749-23-018753
2023-06-0107:01 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001654954-23-007456
2023-05-1107:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001654954-23-006120
2023-05-1107:01 ET10-QQuarterly reportPeriod 2023-03-310001654954-23-006119
2023-04-2816:18 ETDEF 14AProxy statementPeriod 2023-06-270001654954-23-005414
2023-03-2717:01 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001654954-23-003607
2023-03-2307:05 ET10-KAnnual reportPeriod 2022-12-310001654954-23-003384
2023-03-2307:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001654954-23-003383
2023-02-2707:01 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001654954-23-002082
2023-02-1407:01 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001654954-23-001634
2023-01-2607:02 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001654954-23-000825
2023-01-1807:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001654954-23-000519
2022-12-1207:26 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001654954-22-016326
2022-11-1607:20 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001654954-22-015397
2022-11-1008:01 ET10-QQuarterly reportPeriod 2022-09-300001654954-22-014939
2022-11-1008:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001654954-22-014938
2022-10-0508:05 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001654954-22-013366
2022-08-1108:12 ET10-QQuarterly reportPeriod 2022-06-300001654954-22-011015
2022-08-1108:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001654954-22-011014
2022-06-3016:08 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results0001654954-22-009047
2022-05-1209:41 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001654954-22-006509
2022-05-1209:41 ET10-QQuarterly reportPeriod 2022-03-310001654954-22-006507

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 18:09 ET. Listed shows no prices and gives no investment advice.